NCT01097655View on ClinicalTrials.gov

Study on the Usage, Dosing, Tolerability, and Effectiveness of Kaletra Tablet

CompletedOBSERVATIONAL

Enrollment

3,049

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions

Human Immunodeficiency Virus

Sponsors

Collaborators (1)

Veeda Clinical Research

All Listed Sponsors

collaborator

Veeda Clinical Research

INDUSTRY

lead

AbbVie (prior sponsor, Abbott)

INDUSTRY

NCT01097655 - Study on the Usage, Dosing, Tolerability, and Effectiveness of Kaletra Tablet | Biotech Hunter | Biotech Hunter